Announced
Financials
Tags
Acquisition
Pending
Private Equity
Cross Border
Biotechnology
biotechnology
United States
Private
Single Bidder
Majority
Friendly
testing inspection and certification
Synopsis
Cinven, a private investment firm, agreed to acquire a majority stake in BioAgilytix, a provider of molecular bioanalysis and bioanalytical test services, from Caledonia Investments, a London-based investment trust. Cobepa, a private investment firm, and GHO Capital will remain a significant minority investor in the company. Financial terms were not disclosed. "As we move into our next chapter of our evolution, Cinven will provide the additional resources that will empower us to expand not only our geographical reach but will also enable us to invest further in our talent and facilities around the globe to meet the ever-growing needs of our customers," Jim Datin, BioAgilytix President and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.